chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few hours after receiving the vaccine, I had the muscle pain in my left upper arm, as expected. This time it felt a bit different and by the evening, I had my daughter check the site because it felt to me as if I had a hard metal plate protecting my arm. Everything looked good. The next day the pain continued, but it was a bit duller. That evening, however, I woke up with intense shoulder pain. I was confused why I was in so much pain. I was on my back and there was nothing obstructing my shoulder. When I got up the morning of 3/13, I was in intense pain and had limited mobility of my left arm. I took 600 mg of ibuprofen, but that didn't help. I went in to see the doctor and she prescribed naproxen and has referred me to physical therapy. In the meantime, I continue to be in severe pain and my left arm (dominant arm :() is extremely limited.
This spontaneous report was received from a registered nurse, referring to multiple unspecified patients. The patients' medical history, concomitant medications, concurrent conditions, drug and allergy history were not provided. It was reported that on unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23, lot number M037533, expiration date 17-MAY-2018 (dosage and administration route were not reported) for prophylaxis. Temperatures and time frames registered in the data logger, were: 0°Centigrades (C) to 1°C (0.8°C) for 34 hours; 9°C to 25°C (8.7°C) for 27 hours and 26°C or warmer (26.2°C) for 27 hours. No adverse effects were reported. This is one of of several reports from the same reporter. Sender's Comments: US-009507513-1707USA005547: US-009507513-1707USA005549: US-009507513-1707USA005550: US-009507513-1707USA005551: US-009507513-1707USA004510.
LOCAL TITLE: EMERGENCY                                           STANDARD TITLE: EMERGENCY MEDICINE NOTE                          DATE OF NOTE: JAN 15, 2022@11:42:02  ENTRY DATE: JAN 15, 2022@11:42:02             AUTHOR:            EXP COSIGNER:                                 URGENCY:                            STATUS: COMPLETED                          *** EMERGENCY Has ADDENDA ***  ER Triage Note   Pt., a 69 year old FEMALE presents to Emergency   Department on 01/15/22 11:28.       Tetanus status: Last Tdap: Jul 29, 2019      LMP:    Chief Complaint: Visit CC: + covid,back pain and stomach pain  Pt. is a 69 year old FEMALE who is being admitted to the Hospital. This patient meets inpatient  level of care because of need for supplemental O2 and remdesivir.  ASSESSMENT/PLAN: 69 yo lady with obesity, HTN, LBBB with Covid 19 infection and ambulatory  hypoxia.  # Covid 19 - tested positive 1/13/22  Pt., a 69 year old FEMALE currently  was admitted on JAN 16,2022 17:04.The patient is being discharged 20-Jan-2022.
24hr p/vax pt devel irritability & screaming x 4 days;PE nl;
From initial information received on 4/21/04 from the patient regarding an adverse event occurring in the USA, it was reported that a 48 year old female patient received an IMOVAX RABIES vaccination, lot number unknown, administered in the deltoid on 9/20/03. The patient completed the series between 9/30/03 and 10/25/03. Since 9/23/03, the patient experienced malaise, fatigue, weakness, crawling and not walking, dizziness and severe fingertip twitching, but is afebrile. She has symptoms, but they are slowly resolving. From additional information received on 5/10/04 from a healthcare professional, it was reported that the patient had no illnesses at the time of vaccination. The complete patient address and the correct spelling of the city for the responsible physician were provided. It was not reported whether the patient recovered. No further information is anticipated, this case is considered closed.
2 significant spells, one 5 minutes after second dose of vaccine, causing patient to feel very dizzy and felt like passing out; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (2 significant spells, one 5 minutes after second dose of vaccine, causing patient to feel very dizzy and felt like passing out) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Thyroid cancer, Thyroidectomy and Lupus anticoagulant hypoprothrombinemia syndrome since an unknown date. Concurrent medical conditions included Syncope vasovagal, Hashimoto's disease, Menopause and Sleep disorder. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease, ALLOPURINOL (ELAVIL [ALLOPURINOL]) for Menopause and Sleep disorder, MAGNESIUM and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced DIZZINESS (2 significant spells, one 5 minutes after second dose of vaccine, causing patient to feel very dizzy and felt like passing out). The patient was treated with ALPRAZOLAM (XANAX) at a dose of 1 dosage form. On 02-Feb-2021, DIZZINESS (2 significant spells, one 5 minutes after second dose of vaccine, causing patient to feel very dizzy and felt like passing out) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-074923 (Patient Link).
approx 130PM mom noticed nail beds, lips & generalized blueness; phoned clinic 2PM advised to call MD or go to ER; mom denied limpness @ that time; stated pt responsive; mom states p/hanging up phone pt did became limp & rash.
Patient received dose 1 of Pfizer-BioNTech COVID-19 vaccine on Sunday 9/19/2021 and c/o a headache (onset 30 minutes after injection, duration 3 days, did not improve with 2 caps Tylenol QD), fatigue, and an injection site bruise the size of a golf ball with a surrounding ring 3-4 inches from the injection site. On Monday 9/20/2021, she c/o numbness on the left side of her face around her cheek and jaw that lasted for ~4 hours and was not accompanied by tingling or pain. She reported experiencing 1 episode of facial numbness every day that week that lasted a few hours each time, resolved and returned the next day. On Saturday, 9/25/2021, she reported an episode of numbness involving her entire face from the eyes down, without tingling sensation. She is unable to feel her fingernail against her face during these episodes and they appear to be worsening/increasing in severity rather than stabilizing or improving.
Patient is past 42 days of dosing interval; This spontaneous case was reported by a health care professional and describes the occurrence of OFF LABEL USE (Patient is past 42 days of dosing interval) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Patient is past 42 days of dosing interval). At the time of the report, OFF LABEL USE (Patient is past 42 days of dosing interval) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment information were reported.
Gave 0.5ml third full dose instead of half shot booster.; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Nov-2021 and was forwarded to Moderna on 03-Nov-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Gave 0.5ml third full dose instead of half shot booster.) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 02-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (Gave 0.5ml third full dose instead of half shot booster.). On 02-Nov-2021, ACCIDENTAL OVERDOSE (Gave 0.5ml third full dose instead of half shot booster.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. List of concomitant medication were not given.   This case was linked to MOD-2021-374517 (Patient Link).
sore arm; Headache; Extreme Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), HEADACHE (Headache) and NAUSEA (Extreme Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN and AJMALINE (CARDIA) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Extreme Nausea). On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with FAMOTIDINE (PEPCID [FAMOTIDINE]) at a dose of 1 dosage form; ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of 1 dosage form and PEPPERMINT [MENTHA X PIPERITA] at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) was resolving and NAUSEA (Extreme Nausea) had not resolved.            Treatment provide included bland diet, ginger ale, and ginger tea. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: TCR received and updated event(Sore arm) onset date
Information has been received from a medical assistant referring to unknown number of unspecified patients of unknown age and gender.   The patients' medical history, concurrent conditions and concomitant medications were not provided. On some unspecified dates the patients might have received an unknown number of doses of RECOMBIVAX HB (lot # M018625, expiration date 11-AUG-2018, dose, route and site of administration unknown) for prophylaxis. The vaccines were administrated after a temperature excursion to 29.29 degrees Fahrenheit for 111 hours. No adverse effect was reported in any patients. This is one of two reports received from the same source. Additional information has been requested. Sender's Comments:  US-009507513-1612USA009524.
SORENESS ON THE LEFT ARM; This spontaneous report received from a parent concerned a 29 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced soreness on the left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from soreness on the left arm. This report was non-serious.
rapid heart beat, shortness of breath upon exertion, kidney function not up to normal any more
No affects on patient. Received Pfizer for first dose. Refused second dose initially then facility ran out of Pfizer by the time patient requested to have second dose. Was given Moderna instead.
12/2/21 Patient presents with  o Cough     5th day of sx     Reports cough since Sunday.   Some improved today Denies fever of soa  Some nasal congestion and pnd  The current episode started in the past 7 days. The problem has been unchanged. The problem occurs constantly. The cough is productive of sputum (white). Associated symptoms include postnasal drip and a sore throat ( at the start, resolved ). Pertinent negatives include no chills, ear pain, fever, rhinorrhea, shortness of breath or wheezing. She has tried OTC cough suppressant (stahist ) for the symptoms. The treatment provided significant relief. 12/2/21 Review of Systems  Constitutional: Negative for activity change, appetite change, chills, diaphoresis, fatigue and fever.  HENT: Positive for congestion, postnasal drip and sore throat ( at the start, resolved ). Negative for ear pain, rhinorrhea, sinus pressure and sinus pain.   Respiratory: Positive for cough. Negative for shortness of breath and wheezing.   Gastrointestinal: Negative for diarrhea, nausea and vomiting.
nausea, severe body aches, headache, felt very cold, weak, sore arm all subsided by 1/9/21 except sore arm
This is a spontaneous report received from a non-contactable reporter(s) (Nurse) from product quality group. A 28-year-old male patient received BNT162b2 (BNT162B2), on 29Mar2021 as dose 1, single (Lot number: E6955), on 19Apr2021 as dose 2, single (Lot number: EP6955) and on 14Dec2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 27 years for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Jun2022, outcome "unknown" and all described as "Covid test result Positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jun2022) Positive, notes: Nasal Swab; (09Jun2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, Covid-19. If other vaccine in four weeks was unknown. Adverse event: SX GI upset and diarrhea 09Jun with two positive tests AG likely exposure taking public transport. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. No follow-up attempts are Possible: No further information is expected. Sender's Comments: As there is limited information in the case provided, the causal association between the reported events: "Vaccination failure", "COVID-19" and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Patient reported a week after she received the vaccine she started feeling  a lump above the injection site, then the lump moved down to her left hand. She reported than now the top of his left foot is swollen. She reported that this has never happened before. Patient reported that she has taken Advil, warm compressed her left foot nd she is not getting better or worse. She was advised to go to the doctor or urgent care ASAP
Within the hour of receiving the vaccine: Lips began tingling, feeling numb, similar to my allergic reaction. Next morning I had a metallic taste in my mouth but by afternoon had lost my sense of taste.
Got the last of the hpv vaccine woke the next day with sore swollen ankles. Got worse went back to the doctor who administered the vaccine and talked to him about this reaction. I got worse to the point where I can hardly walk and am in pain so I went to urgent care.
pt recv vax early afternoon 22SEP97 that evening father noticed red blotches & sl swelling of feet & blotches of arms & legs;spitting up of formula & brought child back to MD 23SEP;
This case was reported by a consumer via call center representative and described the occurrence of Meniere's disease aggravated in a female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of dizziness (for tolerance of 1st dose, refer case US2019GSK022470). Concurrent medical conditions included Meniere's disease (The patient had a medical history of Meniere's disease which has been in remission for 2 years). On 27th December 2018, the patient received the 2nd dose of SHINGRIX. In January 2019, less than a month after receiving SHINGRIX, the patient experienced Meniere's disease aggravated (serious criteria GSK medically significant), dizzy spells, nausea, vomiting, headache, debility and driving ability disturbed. Rechallenge with SHINGRIX was positive. On an unknown date, the outcome of the Meniere's disease aggravated, dizzy spells, nausea, vomiting, headache, debility and driving ability disturbed were unknown. It was unknown if the reporter considered the Meniere's disease aggravated, dizzy spells, nausea, vomiting, headache, debility and driving ability disturbed to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. For the past two weeks, the patient had a couple of bouts of dizziness, nausea, vomiting, headache which was debilitating. The patient was unable to drive when experiencing this. The patient has a call into her physician and was wondering if the shot has made her more susceptible to these bouts. The patient would call back if has additional information to provide. This was all the patient wanted to share at this time. It was okay to contact patient back regarding this report.
Developed atopic eczema after AVA #3.  Symptom: Dermatitis, diffuse, generalized. Follow-up: It took me so long to report this because I was not aware the reason I was having problems was adverse effect from the Anthrax Vaccine. I had a chemical test in 2006, and my results stated that I am allergic to a chemical in the Vaccine, which may have given me this skin disease. My symptoms are rashes, which I later found out was eczema. My first episode of eczema was when I was deployed in 2001. I started breaking out after the third Anthrax Vaccine was administered. I came back to the states, and saw my primary doctor numerous times and he told me I had a "desert funk". The rash was so bad that I was bleeding on my arms, legs and stomach. My face had numerous rashes, which caused my left eye to swell shut. After numerous doctor visits, they finally referred me to an off base dermatologist. He took one glance at me and told me it was eczema. After numerous steroid shots and pills, I finally got it somewhat under control. To this day, I still have to see a dermatologist on a regular basis. I use numerous steroid creams to keep the eczema somewhat under control. I always have lesions on my hands and rashes on my legs and arms. My skin itches to the point that it sometimes feels like it is crawling. No one in the history of my family has ever had any skin problems. I truly believe my eczema is an adverse effect of the Anthrax Vaccine.
Information has been received from a nurse practitioner concerning a 45 year old female patient with asthma and many allergies (including pollen allergy, codeine allergy and KEFLEX allergy) who on 27-SEP-2010 was vaccinated subcutaneously rather than intramuscularly with a dose of PNEUMOVAX 23 (lot# not reported) in her left upper arm. Concomitant therapy included ADVAIR. On 27-SEP-2010, six hours after she received the vaccine, she began to be febrile and her arm became red, swollen and painful. She sought medical attention with the nurse practitioner on 29-SEP-2010 who prescribed steroids and antihistamines. The symptoms continued to worsen, and the patient went to the Emergency Department on 30-SEP-2010. She was prescribed BACTRIM, and after 7 days of BACTRIM the redness had gone away but her arm was still hard, swollen and painful. She was improving, but the nurse practitioner said that her recovery was slow. Additional information has been requested.
pm 9/10 - T 101.  9/16 rash - describes as red whelps - but house very hot - she's been canning vegetables/onions.  5am Temp 100.2.  Saw Dr. 9/18 - ear infection - and improved once Ab started.
Dizziness; Symptoms worsened; Loss of balance; Tinnitus; Migraine headaches; Vertiginous symptoms; N/V; N/V; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), CONDITION AGGRAVATED (Symptoms worsened), BALANCE DISORDER (Loss of balance), TINNITUS (Tinnitus) and MIGRAINE (Migraine headaches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included GERD. Concurrent medical conditions included Hypothyroidism and Osteopenia.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness), CONDITION AGGRAVATED (Symptoms worsened), BALANCE DISORDER (Loss of balance), TINNITUS (Tinnitus), MIGRAINE (Migraine headaches), VERTIGO (Vertiginous symptoms), NAUSEA (N/V) and VOMITING (N/V). The patient was treated with OXITRIPTAN (TRIPTAN [OXITRIPTAN]) for Adverse event, at an unspecified dose and frequency; OMEPRAZOLE for Adverse event, at an unspecified dose and frequency and ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (Dizziness), CONDITION AGGRAVATED (Symptoms worsened), BALANCE DISORDER (Loss of balance), TINNITUS (Tinnitus), MIGRAINE (Migraine headaches), VERTIGO (Vertiginous symptoms), NAUSEA (N/V) and VOMITING (N/V) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Full blood count: normal (normal) normal. On an unknown date, Metabolic function test: normal (normal) normal. On an unknown date, Thyroid function test: normal (normal) normal. On an unknown date, Vitamin D: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The reporter stated that symptoms resolved after 3 months.   This case was linked to MOD-2021-278248 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow up contains No New Information. On 17-Aug-2021: Follow-up received contains NNI.
At  approximately 3am (11 hrs after vaccine), had chills, body aches, severe headache, dizziness. Chills lasted about 4-5 hours, body aches x 24 hrs, and headache 24 hrs.
Cold sweats, heart palpitations, racing heat, chest pain, shortness of breath, numbness and tingling in extremities, head ache, light headedness, joint and muscle pain, diarrhea, and pain at injection site.
Left arm at Dtap injection site is red, swollen and warm to touch. Right arm where MMRV was administered is red and warm to touch, appears to be a hive.
Pruritic hands, followed on 5/13/2010 by hives on hands, left knee, bilateral medial thighs, and right upper arm under injection site.
patient reported experiencing sharp pain to her lower back; felt clammy and dizzy. the symptoms developed 5-10 minutes after receiving her flu vaccine. she was seated and given water and expressed she was feeling better after a few minutes. she declined 911 help and left on her own accord.